Table 2.
Relative expression level of Psoralen group over that Control group
| Gene symbol | Control | Psoralen | log2FoldChange | P value |
|---|---|---|---|---|
| KRTAP2-3 | 473.4431128 | 77.96785331 | −2.602239769 | 1.55E-31 |
| FOSL1 | 11296.63679 | 5566.561955 | −1.021034857 | 3.49E-26 |
| MMP1 | 1170.248705 | 212.1662542 | −2.463548055 | 1.18E-13 |
| MYPN | 456.4454562 | 187.019253 | −1.287255674 | 1.63E-10 |
| ENSG00000231826.1 | 761.8035897 | 366.7059488 | −1.054795416 | 7.26E-08 |
| ALPP | 320.5900834 | 127.107873 | −1.334676407 | 1.22E-07 |
| ENSG00000237862.1 | 247.8975043 | 105.2724733 | −1.235615498 | 1.45E-07 |
| LRRC15 | 313.4134599 | 144.8134519 | −1.113871516 | 3.37E-07 |
| TMEM40 | 398.6759476 | 196.9516533 | −1.017375042 | 5.19E-07 |
| ALPL | 205.4467798 | 88.21207065 | −1.21971673 | 1.31E-06 |
| TMEM200A | 714.8598445 | 303.7664782 | −1.234697743 | 3.42E-06 |
| LCE2A | 455.8712616 | 224.9098164 | −1.019279833 | 8.62E-06 |
| SIRPB1 | 43.66423935 | 9.736212337 | −2.165019671 | 1.03E-05 |
| SESN3 | 73.33189937 | 163.1626044 | 1.153797628 | 1.94E-05 |
| PEAR1 | 195.9475924 | 80.66338615 | −1.280481972 | 2.38E-05 |
| HSD17B6 | 83.7271271 | 31.44521183 | −1.412854769 | 3.95E-05 |
| ENSG00000261159.1 | 17.47612762 | 1.611337899 | −3.439054581 | 6.33E-05 |
| INHBA | 92.57825197 | 34.35526917 | −1.430141936 | 6.82E-05 |
| ARNT2 | 115.3737968 | 50.98582145 | −1.17814759 | 8.87E-05 |
| IGFN1 | 87.83302938 | 31.6306287 | −1.473441332 | 1.02E-04 |
| RXFP4 | 0 | 10.4296342 | Inf | 1.26E-04 |
The table displays the results of the RNA-Seq data comparison before and after psoralen treatment. It holds the description, log2 fold change (FC) of the differentially expressed genes. Positive log2 fold changes indicate higher gene expression after psoralen treatment, while negative log2 fold changes indicate lower gene expression after psoralen treatment